Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML Sutro Biopharma, Inc. Fri, Nov 1, 2024, 8:00 AM 7 min read ...

Fraudsters have been posing as dentists to take advantage of patients desperate for NHS appointments. But how does the scam ...

York County Commissioner Julie Wheeler provided an update on the investigation into flagged voter registration forms. She ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

"We are excited to announce the initiation of our second pivotal trial, the registration-enabling clinical trial of luvelta in infants and toddlers with a rare and aggressive form of leukemia,” said ...

One Latino civil rights organization has released a new set of guidelines to inform people of their federally-protected ...

Long queues at Government Medical College Hospital in Kozhikode due to delays in e-Health project implementation.

Multiple clinical trial milestones were achieved, including encouraging topline data for a Phase 2 trial in CCM, the first ...

New research from The Patients Association, supported through sponsorship provided by Novo Nordisk and ENGINE MHP, looks at how more than 950 patients experienced the COVID-19 pandemic ...

A suite of information for GP partners, practice managers and doctors to use to ensure your practice is compliant and delivering the best patient care. Safe working and managing workload in general ...

For people suffering from various rare forms of blood cancer, acalabrutinib offers the promise of improved life quality by reducing serious side effects — namely suppressed immune systems that left ...

Patient flow forecasting is a fundamental tool in healthcare and pharmaceutical industries, enabling stakeholders to predict and plan for the treatment requirements of patients accurately.